LB Pharmaceuticals Inc (LBRX)
$37.22+7.54%Close
SELLCRISIS · day 13
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.1B
- Beta
- 0.42
- P/E (TTM)
- -11.54
- Short % float
- 28.95%
- Days to cover
- 14.5
- SI change
- +7.0%
- 1W
- +0.62%
- 1M
- -19.52%
- vs SPY 1W
- -0.54%
- vs SPY 1M
- -22.52%
Industry peers
FMP comparable companies · ranked by market cap
- DFTXSELLDefinium Therapeutics, Inc.$4.9BBEARQ 26$36.90+7.96%
- ACADSELLAcadia Pharmaceuticals Inc.$3.4BCRISISQ 18$19.78+1.02%
- DNLISELLDenali Therapeutics Inc.$3.1BCRISISQ 8$19.45+4.18%
- RAPPSELLRapport Therapeutics, Inc. Common Stock$1.5BCRISISQ 26$30.65+2.68%
- GHRSSELLGH Research PLC$1.4BCRISISQ 16$21.11+3.23%
- SPTXSELLSeaport Therapeutics, Inc. Common Stock$972MQ -0$18.15+1.34%
- ANROSELLAlto Neuroscience, Inc.$855MCRISISQ 17$24.37+1.41%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
